I agree that this site is using cookies. You can find further informations here.
X
Janjigian, Yelena Y
164  results:
Search for persons X
?
1

Patient metabolic profile defined by liver and muscle 18F-F..:

Vitiello, Gerardo A. ; Jayaprakasam, Vetri Sudar ; Tang, Laura H....
Gastric Cancer.  27 (2024)  3 - p. 548-557 , 2024
Link: https://doi.org/10.1007/..
 
?
2

Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in..:

Shitara, Kohei ; Rha, Sun Young ; Wyrwicz, Lucjan S...
The Lancet Oncology.  25 (2024)  2 - p. 212-224 , 2024
Link: https://doi.org/10.1016/..
 
?
3

A plain language summary of the CheckMate 649 study: nivolu..:

Janjigian, Yelena Y ; Shitara, Kohei ; Moehler, Markus...
Future Oncology.  19 (2023)  11 - p. 739-752 , 2023
Link: https://doi.org/10.2217/..
 
?
4

Neoplasia risk in patients with Lynch syndrome treated with..:

Harrold, Emily C. ; Foote, Michael B. ; Rousseau, Benoit...
Nature Medicine.  29 (2023)  10 - p. 2458-2463 , 2023
Link: https://doi.org/10.1038/..
 
?
5

Pembrolizumab plus trastuzumab and chemotherapy for HER2-po..:

Janjigian, Yelena Y ; Kawazoe, Akihito ; Bai, Yuxian...
The Lancet.  402 (2023)  10418 - p. 2197-2208 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Clinical and molecular characteristics of early-onset vs av..:

Lumish, Melissa A ; Walch, Henry ; Maron, Steven B...
JNCI: Journal of the National Cancer Institute.  116 (2023)  2 - p. 299-308 , 2023
Link: https://doi.org/10.1093/..
 
?
7

Reversion mutations in germline BRCA1/2-mutant tumors revea..:

Murciano-Goroff, Yonina R. ; Schram, Alison M. ; Rosen, Ezra Y....
Nature Communications.  13 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
8

Top advances in esophageal/gastroesophageal junction cancer..:

Cowzer, Darren ; Janjigian, Yelena Y.
Cancer.  128 (2022)  10 - p. 1894-1899 , 2022
Link: https://doi.org/10.1002/..
 
?
9

MATTERHORN: phase III study of durvalumab plus FLOT chemoth..:

Janjigian, Yelena Y ; Van Cutsem, Eric ; Muro, Kei...
Future Oncology.  18 (2022)  20 - p. 2465-2473 , 2022
Link: https://doi.org/10.2217/..
 
?
10

Nivolumab plus chemotherapy or ipilimumab in gastro-oesopha..:

Shitara, Kohei ; Ajani, Jaffer A. ; Moehler, Markus...
Nature.  603 (2022)  7903 - p. 942-948 , 2022
Link: https://doi.org/10.1038/..
 
?
11

Phase I/Ib study of crenolanib with ramucirumab and paclita..:

Moy, Ryan H. ; Greally, Megan ; Chou, Joanne F....
Cancer Chemotherapy and Pharmacology.  89 (2022)  2 - p. 255-265 , 2022
Link: https://doi.org/10.1007/..
 
?
12

A nutritional management algorithm in older patients with l..:

Moy, Ryan H. ; Sabwa, Shalom ; Maron, Steven B....
Journal of Geriatric Oncology.  13 (2022)  1 - p. 100-103 , 2022
Link: https://doi.org/10.1016/..
 
?
13

ATM Germline-Mutated Gastroesophageal Junction Adenocarcino..:

El Jabbour, Tony ; Misyura, Maksym ; Cowzer, Darren...
JNCI: Journal of the National Cancer Institute.  114 (2022)  5 - p. 761-770 , 2022
Link: https://doi.org/10.1093/..
 
?
14

Caveolin-1 temporal modulation enhances antibody drug effic..:

Pereira, Patrícia M. R. ; Mandleywala, Komal ; Monette, Sébastien...
Nature Communications.  13 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
15

The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER..:

Janjigian, Yelena Y. ; Kawazoe, Akihito ; Yañez, Patricio...
Nature.  600 (2021)  7890 - p. 727-730 , 2021
Link: https://doi.org/10.1038/..
 
1-15